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Background: Tuberculosis is still the leading cause of illness in the world which accounted for 2.5% of the global
burden of disease, and 25% of all avoidable deaths in developing countries. The aim of study was to assess impact
of DOTS strategy on tuberculosis case finding and treatment outcome in Gambella Regional State, Ethiopia from
2003 up to 2012 and from 2002 up to 2011, respectively.
Methods: Health facility-based retrospective study was conducted. Data were collected and reported in quarterly
basis using WHO reporting format for TB case finding and treatment outcome from all DOTS implementing health
facilities in all zones of the region to Federal Ministry of Health.
Results: A total of 10024 all form of TB cases had been registered between the periods from 2003 up to 2012. Of
them, 4100 (40.9%) were smear-positive pulmonary TB, 3164 (31.6%) were smear-negative pulmonary TB and 2760
(27.5%) had extra-pulmonary TB. Case detection rate of smear-positive pulmonary TB had increased from 31.7% to
46.5% from the total TB cases and treatment success rate increased from 13% to 92% with average mean value of
being 40.9% (SD = 0.1) and 55.7% (SD = 0.28), respectively for the specified year periods. Moreover, the average
values of treatment defaulter and treatment failure rates were 4.2% and 0.3%, respectively.
Conclusion: It is possible to achieve the recommended WHO target which is 70% of CDR for smear-positive pulmonary
TB, and 85% of TSR as it was already been fulfilled the targets for treatments more than 85% from 2009 up to 2011 in
the region. However, it requires strong efforts to enhance case detection rate of 40.9% for smear-positive pulmonary TB
through implementing alternative case finding strategies.
Keywords: Gambella Regional State, Case detection rate, Directly observed treatment short-course, Treatment success
rate, TuberculosisBackground
Tuberculosis (TB) is a bacterial disease caused mainly by
mycobacterium tuberculosis, which is an acid fast and
rod shaped bacillus [1]. TB is still the leading cause of
illness worldwide which accounted for 2.5% of global
burden of disease. About a third of the world’s popula-
tion is estimated to be infected with tubercle bacilli, and
hence at risk of developing active disease [2]. According
to world health organization (WHO) global TB report in
2011, there were globally an estimated 9 million incident* Correspondence: desalegn01@gmail.com
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stated.cases of TB. Of which, 1.2 million were among people liv-
ing with HIV. Annual number of deaths due to TB was 1.6
million, including 195000 patients infected with HIV [3].
In developing countries, TB comprised 25% of all avoid-
able adult deaths. It is estimated that nearly one million
(11%) of the total TB cases were children whose age less
than 15 years. About 26% of TB incident cases occurred
in Africa in 2010 [2]. Moreover, 22 high burden countries
(HBCs) accounted for approximately 80% of the estimated
number of new all form of TB cases which rising world-
wide on the same year. In Africa, those countries with
high rates of TB/HIV co-infection are the main focus of
intensified efforts in directly observed treatment short-
course (DOTS) expansion. Ethiopia was ranked seventh
among the world 22 high burden countries (HBCs) [3].d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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survey was conducted by Ethiopian Health Nutrition
and Research Institution (EHNRI) from 2010 up to 2011
which revealed that the prevalence of smear positive TB
among adults and all age group were found to be 108
cases and 63 cases per 100000 populations, respectively.
The prevalence of bacteriologically confirmed TB was
found to be 156 cases per 100000 populations, and the
prevalence of all forms of TB in Ethiopia was estimated
to be 240 cases per 100000 populations [4].
According to WHO global TB report in 2012, which
considered the findings from the national TB prevalence
survey, there were an estimated 220000 (258 cases per
100000 populations) incident cases of TB in Ethiopia in
2011. The same report mentioned that the prevalence of TB
was estimated to be 200000 (237 cases per 100000 popula-
tions). Additionally, there were an estimated 15000 deaths
(18 deaths per 100000 populations) due to TB, excluding
HIV related deaths in the country [5]. Hospital statistics data
of federal ministry of health (FMoH) revealed that tuber-
culosis is the leading cause of morbidity, the third cause of
hospital admission (after deliveries and malaria), and the
second cause of death in Ethiopia after malaria [2].
Hence, FMoH adopted DOTS strategy for TB control
program in 2000 which was piloted before in a few areas of
the country [6]. Then, a number of similar researches were
conducted in some parts of the country for assessing experi-
ence of DOTS program for TB control in which the findings
revealed that there were more gaps in organizational issues
such as misuse and under use of TB registration book,
challenges in follow-up of TB patients, low case detection of
TB and increased rate of treatment defaulter [7].
Even though it is critical to evaluate the impact of
DOTS program, more studies still remained to be car-
ried out at different level of programmatic management
including health facilities which provide direct treatment
service to the community. Therefore, the study aimed at
evaluating impact of DOTS program in Gambella Regional
State on TB case finding and treatment outcome from
2003 up to 2012 and from 2002 up to 2011, respectively.
Methods
Study design
Health facility-based retrospective data was collected for
TB cases who registered during the study period from
2003 up to 2012 and for their treatment outcome in
Gambella Regional State from 2002 up to 2011.
Study area
Gambella Regional State consisted of 4 administrative
zones, 8 districts and 7 towns which was far 777 km from
west of capital city, Addis Ababa. Rural parts of the region
had 174 kebeles, while urban parts had 8 kebeles. Size of
population in the region, for the year 2007 nationalcensus, was about 307096. Out of which, 159787 (52%)
were males and 147309 (48%) females [8]. DOTS program
was initiated in the region in 1993, and in 2011, DOTS
coverage among public facilities like hospitals and health
centers reached 100% and 75%, respectively while, it was
only 11% among health posts. Currently, the program is
being implemented in 1 government hospital, 21 health
centers (17 governments and 4 NGOs), 7 health posts, 9
lower clinics (8 governments and 1 NGO) [9].
Inclusion and exclusion criteria
All forms of TB cases who registered during the study period
were included in the study. Treatment outcome of extra-
pulmonary tuberculosis and smear-negative pulmonary
tuberculosis cases were excluded as treatments outcome
mainly focuses on smear-positive pulmonary tuberculosis
cases due to their infectiousness than other forms of TB.
Data collection procedures
Data were collected by world health organization
(WHO) standardized reporting formats for case detec-
tion and treatment outcome. Reports from all zones in
the region were collected by trained data collectors and
investigators. Data were first collected from health facil-
ities (HF) where TB focal persons compiled the data and
reported it on quarterly basis about all TB patients en-
tered into TB clinic thereby assigning a unique TB registra-
tion number for each TB patients and submitted the report
to zonal TB focal persons who were responsible for com-
piling zonal summary, and in turn, the zonal TB focal per-
sons submitted report to regional TB program officer.
Regional TB program officer checked completeness, qual-
ity and accuracy of reports. Then, data were analyzed and
interpreted, and sent as compiled report to the office of na-
tional tuberculosis and leprosy control program (NTLCP)
office, federal ministry of health (FMoH).
Data analysis
Data which were collected and reported from standard-
ized WHO formats were analyzed and interpreted using
SPSS version 17.0 packages. Data were summarized using
frequencies, percentages and standard deviations includ-
ing for mean values of variables like case detection rate,
treatment success rate, death rate and defaulter rate.
Data validation
Federal Ministry of Health (FMoH) used health manage-
ment information system (HMIS) for all health program
recording and reporting, which consisted of its own
unique data collection book and reporting format. Data
obtained by WHO reporting formats were crosschecked
for the data obtained in HMIS for maintaining consistency
of information within the study period.
Table 1 Case notifications of all forms of TB by sex in Gambella Regional State from 2003 up to 2012
Smear-positive PTB Smear-negative PTB Extra-pulmonary PTB All forms of TB
Year M (%) F (%) Total (%) CDR (%) M (%) F (%) Total (%) M (%) F (%) Total (%) M F Grand total
2003 295 (17.7) 231 (13.9) 526 (31.7) 31.7 385 (23.1) 300 (18.1) 685 (41.2) 253 (15.2) 198 (12) 451 (27.1) 930 732 1662
2004 175 (22) 138 (17.3) 313 (39.4) 39.4 126 (15.9) 98 (12.5) 224 (28.2) 44 (18.1) 113 (14.2) 257 (32.4) 445 349 794
2005 286 (26.7) 225 (21) 511 (47.6) 47.6 108 (10.1) 84 (7.8) 192 (17.9) 207 (19.3) 163 (15.2) 370 (34.5) 601 472 1073
2006 338 (20.5) 302 (18.3) 640 (38.7) 38.7 256 (15.5) 201 (12.2) 457 (27.6) 312 (18.9) 244 (14.8) 556 (33.6) 926 727 1653
2007 250 (25) 196 (19.6) 446 (44.5) 44.5 217 (21.7) 170 (17.1) 388 (38.7) 94 (9.4) 74 (7.4) 1689 (16.8) 561 441 1002
2008 91 (16.6) 77 (14) 168 (30.6) 30.6 127 (23.1) 99 (18) 226 (41.2) 87 (15.9) 68 (12.4) 155 (28.2) 308 241 549
2009 194 (26.4) 103 (14) 297 (40.4) 40.4 132 (18) 104 (14.1) 236 (32.1) 114 (15.5) 89 (12.1) 203 (27.6) 412 324 736
2010 189 (19.5) 185 (19.1) 374 (38.6) 38.6 185 (19.1) 145 (15) 330 (34.1) 148 (15.3) 116 (12) 264 (27.3) 542 426 968
2011 178 (41.1) 110 (25.4) 288 (66.5) 66.5 44 (10.2) 35 (8.1) 79 (18.2) 37 (8.5) 29 (6.7) 66 (15.2) 243 190 433
2012 301 (26.1) 236 (20.5) 537 (46.5) 46.5 194 (16.8) 153 (13.3) 347 (30.1) 151 (13.1) 119 (10.3) 270 (23.3) 645 509 1154
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Case definitions
Case detection rate: Percentage of smear-positive TB
cases detected among the total number of TB cases esti-
mated to occur.
New case: A patient who has never had treatment for
TB or has been on anti-TB treatment for less than four
weeks.
Relapse: A patient who has been declared cured or
treatment completed from any form of TB in the past
but found to be smear-positive or culture positive.
Return after default: A patient who had previously
been recorded as defaulted from treatment and returns
to the health service with smear-positive sputum.
Treatment out come
Defaulter: A patient who has been on treatment for at
least 4 weeks and whose treatment was interrupted for 8
or more consecutive weeks.
Transfer Out (TO): A patient who has started treat-
ment and has been transferred to another health facility
and for whom treatment outcome is not known at the
time of evaluation.
Cured: A patient who is sputum smear-negative one
month prior to the completion of treatment and on at
least one previous occasion (usually at the end of the
2nd or 5th month).
Treatment completed: A patient who has completed
treatment but in whom smear result are not available at
or one month prior to the completion of treatment.
Treatment failure: A patient who remained smear posi-
tive or became again smear positive at the end of five






































Figure 1 Trend of case finding for all forms of TB cases in Gambella RDied: A patient who dies for any reason during the course
of treatment.
Treatment success rate: A sum of TB cases who com-
pleted treatment and who declared cured.
Ethical considerations
Ethical clearance was obtained from Institutional Review
Board of School of Medicine and Health Science,
AASTU and Ethical Clearance Committee of Gambella
Regional Health Bureau.
Result
A total of 10024 cases were registered with all forms of
TB for the past 10 years (Table 1). Out of which, 4100
(40.9%) were smear-positive pulmonary TB, 3164
(31.6%) smear-negative pulmonary TB, and 2760 (27.5%)
extra-pulmonary TB. Among all forms of TB, 5615
(56%) were male patients and 4409 (44%) females.
Trends of case finding for all forms of TB cases were
shown for the decade (Figure 1).
Among the total smear-positive pulmonary TB cases
(4100), more new smear-positive pulmonary TB cases
were reported each year than re-treatment smear-positive
pulmonary TB cases (defaulter, failure and relapse) in the
region. There were 1433 (35%) new smear-positive pa-
tients while 264 (6.4%) were relapse, 40 (0.9%) were failure
and 219 (5.3%) were returned after default cases in the
study period (Figure 2). Moreover, there were an increased
number of males 123 (3%) who returned after default as
compared females 96 (2.3%). Case detection rate of smear-
positive pulmonary TB had increased from 31.7% to 46.5%
with average value of being 40.9% (SD = 0.1) from the total
TB cases to its peak 66.5% in 2011 and then it decreased
to 30.6% in 2008 (Table 1) (Figure 3).
Out of 4100 smear-positive TB cases, highest number
of cases (1233 (23.1%)) were reported among age group
ranges from 25 up to 34 followed by 374 (7%) in age
group of 15 up to 24 while lowest number of cases (25
(0.5%)) were reported among age group less than 4 years.




















































Figure 2 Number of smear-positive re-treatment case finding of Gambella Regional State from 2003 up to 2012.
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(13.3%) and 523 (9.8%), respectively. Numbers of smear-
positive pulmonary TB cases were higher in males than fe-
males across all age groups (Table 2).
A quarterly report format of WHO for DOTS program
mainly focused on case detection and treatment out-
come for smear-positive pulmonary TB, because smear-
positive pulmonary TB cases were infectious and were
much of a public health importance compared to the
other forms of TB. Treatment outcomes were available
for those patients who were treated by DOTS program
from 2002 up to 2011. Treatment outcome reports of
year 2012 were not included because they were a cohort
for the year 2013 and need to be followed for their out-
come results until next end of the year.
Similarly, a total of 3836 smear-positive pulmonary TB
patients were considered as a cohort for treatment out-
come. Two thousand five hundred-ninety five (67.7%) of
them were evaluated for their treatment outcome from
the period of 2002 up to 2011. Among the total evalu-
ated smear-positive TB cases for treatment, 1177 (30.7%)
were cured and 959 (25%) completed their treatment.




































Figure 3 Trend of case detection rate and treatment success rate of s
2002 up to 2012.Therefore, treatment success rate (TSR) had an aver-
age value of being 55.7% (SD = 0.28) and from 2002 to
2011 with its peak value of being 93.9% in 2010 and it
significantly declined in 2002 by 13.2%. The targets by
WHO for treatment success rate had already been
achieved as it become more than 85% from 2009 on-
wards in the region (Table 3) (Figure 3).
Moreover, cure rate relatively increased from 4.03%
to 44% over the study period. The same was true for
TB patients who had completed their treatment which
ranged from 9.2% up to 47.6%. The average value of
death rate and defaulter rate were found to be 3.9%
(SD = 0.02) and 4.2% (SD = 0.02), respectively. Add-
itionally, failure rate and transfer out rate fluctuated
over the years and reached to the average value of
being 0.3% and 2.9%, respectively (Table 3).
Discussion
The study showed that 10024 cases were registered with
all forms of TB for treatment. Of which, 5615 (56%)
were male patients and 4409 (44%) females. Similar find-
ings were also seen in southern region of the country
[10] and Addis Ababa City Administration [11]. This









2 per. Mov. Avg. (CDR(%))
mear-positive pulmonary TB in Gambella Regional State from
Table 2 Smear-positive pulmonary TB cases by sex and
age groups in Gambella Regional State from 2006 up
to 2011
Age Sex Number (%)
M (%) F (%)
0–4 13 (0.3) 12 (0.2) 25 (0.5)
5–14 59 (1.1) 41 (0.8) 100 (1.9)
15–24 199 (3.7) 175 (3.3) 374 (7)
25–34 710 (13.3) 523 (9.8) 1233 (23.1)
35–44 162 (3) 104 (1.9) 266 (4.9)
45–54 63 (1.2) 51 (1) 114 (2.2)
55–64 40 (0.8) 32 (0.6) 72 (1.4)
65+ 19 (0.4) 10 (0.2) 29 (0.6)
Total 1240 (23.2) 973 (18.2) 2213 (41.4)
NB: N = 5341(Total number of TB patients during the period).
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males were spent their time out side home for work than
females which predisposed them for susceptibility of
TB infection. This was also true for the studies done
on ten year assessment of DOTS program in Oromia
and Benshangul Gumuze Regional States of the country
[12,13]. Additionally, another study done on barriers in
accessing tuberculosis treatment in Gambian women’s
showed that females used traditional healers more, prob-
ably because of stronger traditional beliefs, time con-
straints and increased confidentiality. In the same study,
poor socio-economic condition, lack of knowledge about
TB and stigma were also reported, and worst in female
patients [14]. However, further studies should be needed
to investigate the findings.
An increased number of males 123 (3%) who returned
after default as compared females 96 (2.3%) showed in the
study. A similar study conducted on unsuccessful treat-
ment outcome for DOTS program in South India revealedTable 3 Treatment outcome of smear-positive pulmonary TB
Year Cohortcases (N) Evaluated (%) Cured (%) Completed (%
2002 273 53 (19.4) 11 (4.03) 25 (9.2)
2003 526 313 (59.5) 106 (20.2) 112 (21.3)
2004 313 244 (78) 109 (34.8) 65 (20.8)
2005 511 363 (71) 177 (34.6) 98 (19.2)
2006 640 274 (42.8) 141 (22) 75 (11.7)
2007 446 221 (49.6) 98 (22) 111 (24.9)
2008 168 168 (100) 98 (58.3) 44 (26.2)
2009 297 297 (100) 154 (51.9) 125 (42.1)
2010 374 374 (100) 155 (41.4) 167 (44.7)
2011 288 288 (100) 128 (44.4) 137 (47.6)
Total 3836 2595 (67.7) 1177 (30.7) 959 (25)that more males returned after default from treatment
than females and the findings were significantly associated
with patients’ age ≥ 45 years, previous history of anti-
tuberculosis treatment, being male, case finding by commu-
nity survey, irregularity of treatment during the intensive
phase, alcoholism, type of disease and smoking [15].
The highest numbers of cases (1233 (23.1%)) were ob-
served for smear-positive pulmonary TB among age group
from 25 up to 34 followed by 374 (7%) in age group of 15
up to 24. This might be attributed to increased incidence
of HIV/AIDS and population migration more than others
age groups [16]. Highest numbers of smear-positive pul-
monary TB cases among similar age groups were also
observed by previous studies [12,13].
In the study, case detection rate of smear-positive pul-
monary TB had increased from 31.7% to 46.5% from the
total TB cases registered for the study period. The incre-
ment might be linked to decentralization and expansion
of DOTS program. It might also be explained by the
influence of referred smear-positive pulmonary TB from
other region and the improvement of diagnostic settings
of health facilities in the region [17]. However, the total
average value of CDR was 40.9% for the study period
which was less than WHO target of 70%. A similar re-
sult was obtained on the study done in Addis Ababa City
Administration [11]. Hence, the possible explanation
might be as the CDR relies on an estimate for the
incidence of TB, it is difficult to measure accurately
in most settings especially in the context of a high preva-
lence of HIV [18]. Additionally, the national average CDR
for the year 2008 was 34% [2]. This might be due to inad-
equate decentralization of DOTS program, shortage of
resource and trained personnel, low sensitivity of smear
microscopy and high level of HIV prevalence in the
region.
The study revealed that the average value of treatment
success rate (55.7%) was lower than 85% of WHO targetcases in Gambella Regional State from 2002 up to 2011
) Success (%) Death (%) Failure (%) Default (%) TO (%)
36 (13.2) 9 (3.3) 0 2 (0.7) 6 (2.2)
218 (41.4) 37 (7) 0 27 (5.1) 18 (3.4)
174 (55.6) 23 (7.3) 3 (1) 27 (8.6) 13 (4.2)
275 (53.8) 29 (5.7) 7 (1.4) 32 (6.3) 20 (3.9)
216 (33.8) 15 (2.3) 0 22 (3.4) 21 (3.3)
209 (46.9) 5 (1.1) 0 3 (0.7) 4 (0.9)
142 (84.5) 3 (1.8) 0 1 (0.6) 22 (13.1)
279 (93.9) 4 (1.3) 0 9 (3) 5 (1.7)
322 (86.1) 18 (4.8) 0 31 (8.2) 0
265 (92) 8 (2.8) 2 (0.7) 7 (2.4) 1 (0.3)
2136 (55.7) 151 (3.9) 12 (0.3) 161 (4.2) 110 (2.9)
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[19] from 2002 up to 2008 in the region, but it showed
more than 85% from 2009 onwards. Decrease in treat-
ment success rate (less than 85%) for specified years
might be due to poor observation of patients during the
course of treatment, poor patient treatment compliance,
poor standardized and improper recording and reporting
system, inadequate treatment regimens and increase in
incidence of drug resistant strains. The possible explana-
tions for increase treatment success rate (more than 85%)
from 2009 up to 2011 might be due to adequate treatment
regimens, good adherence to treatment or government
commitment to ensure comprehensive TB control activ-
ities [20].
The average treatment failure rate was about 0.3% for
smear-positive pulmonary TB cases treated by DOTS
program for the same study period. The lower failure
rate could be due to the overall low prevalence of multi-
drug resistant tuberculosis (MDR TB) in Ethiopia which
was 1.6% for new smear positive cases [21].
Conclusion
It is possible to achieve the recommended WHO target
which is 70% of CDR for smear-positive pulmonary TB
as it was significantly increased from 31.7% to 46.5% for
the study period, and 85% of TSR for its treatment out
come as it was already been fulfilled the targets for treat-
ment outcomes (more than 85%) from 2009 up to 2011
in the region. However, it requires strong efforts to
enhance case detection rate (40.9%) for smear-positive
pulmonary TB through implementing alternative case
finding strategies.
Limitation of the study
The existence of poor recording and reporting mechan-
ism in the study at each level of health system which
comprised from health facilities up to the national pro-
gram might have an effect in finding valid and reliable
data for proper monitoring and evaluation of the pro-
gram as the data source was secondary, which was from
DOTS implementing health facilities. In addition, the
expansion and the decentralization of DOTS were not
available at each year in the region, except the current
one and this in turn prevents the study from, for ex-
ample, addressing any possible significant association
either between the expansions of the program with the
current case detection rate and treatment out come.
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